Inactive

The U.S. Food and Drug Administration (FDA), is conducting market research to support the Center for Biologics Evaluation and Research (CBER) requires specialized PET-CT imaging of 3 B. pertussis-infe... The U.S. Food and Drug Administration (FDA), is conducting market research to support the Center for Biologics Evaluation and Research (CBER) requires specialized PET-CT imaging of 3 B. pertussis-infected baboons (6-8 months of age) (research animals) as part of a pilot imaging study required for the evaluation of Pertussis Pathogenesis and the Immune Response to Infection and Vaccination.